Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning about the novel strain of SARS. Human and clinical trials are well underway, but just when they’ll be ready for manufacturing and distribution is another story. What is a realistic timeline and does one exist? We asked Dr. Vincent Silenzio an expert in urban and global public health at Rutgers University. To read the full story.
- Soaring Overdose Rates in the Pandemic Reflected Widening Racial Disparities
- Rutgers Will Conduct the Most Comprehensive Study Ever Done of High-Risk Children Newly Diagnosed With Type 1 Diabetes.
- A U.S.-Russia nuclear war could starve 5 billion to death, study says.
- ‘All of us are living with trauma’
- Association of Clinical and Translational Science Development Roundtable, September 21